Tuesday, March 12, 2013

Merck will continue large study of Vytorin after panel review

Retweeted Medical News (@MedicalNews): Merck Vytorin study to continue after panel review http://t.co/Us2grbxuXR

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/Us2grbxuXR
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)